Dechra
Hy-50 vet 17 mg/ml - horses - 1 syringe of 3 ml

For the treatment of carpal and fetlock joint dysfunction in horses

Prescription required* (Exceptions apply)

HY-50 Vet is a clear, colourless and viscous solution for injection for horses.

Each HY-50 Vet mL contains:

  • Active substance:

    • Hyaluronate sodium 17 mg
  • List of excipients:
    • Sodium chloride 7.57 mg
    • Sodium phosphate dibasic 3.78 mg
    • Sodium phosphate monobasic 0.45 mg
    • Water for injection q.s.

Indications for use of HY-50 Vet, specifying the target species:

  • HY-50 is indicated for the intra-articular or intravenous treatment of carpal and fetlock joint dysfunction in horses due to acute or chronic non-infectious synovitis associated with equine osteoarthritis.

Amounts of HY-50 Vet to be administered and administration route:

  • Intravenous route: The recommended dose of HY-50 is 51 mg hyaluronate sodium (contents of one syringe) once a week for three consecutive weeks.

  • Intra-articular route: The recommended dose of HY-50 is 51 mg hyaluronate sodium (contents of one syringe) in small or medium sized joints (i.e. carpus, fetlock) by intra-articular injection. More than one joint may be treated at the same time. Treatment may be repeated after one or more weeks if necessary, but not to exceed four consecutive weekly injections in the same joint. HY-50 should be administered using strict aseptic technique. The site should be surgically prepared to ensure removal of all dirt, hair, topical medicaments, and soapy residues.

  • Intra-articular injections should not be made through skin that has been recently red or blistered or that has been scurfed by the use of counterirritants. After introducing the needle into the joint, excess synovial uid should be allowed to drain, or should be removed when possible, prior to attaching the syringe and injecting HY-50. Discard any unused portion of a syringe. A sterile dressing and clean bandage should be applied after injection, as appropriate for the particular joint treated. Hand walk for at least 2 days after treatment. Return to strenuous exercise will depend on the severity of each case and the regression of clinical signs.

HY-50 Vet is a clear, colourless and viscous solution for injection for horses.

Each HY-50 Vet mL contains:

  • Active substance:

    • Hyaluronate sodium 17 mg
  • List of excipients:
    • Sodium chloride 7.57 mg
    • Sodium phosphate dibasic 3.78 mg
    • Sodium phosphate monobasic 0.45 mg
    • Water for injection q.s.

Indications for use of HY-50 Vet, specifying the target species:

  • HY-50 is indicated for the intra-articular or intravenous treatment of carpal and fetlock joint dysfunction in horses due to acute or chronic non-infectious synovitis associated with equine osteoarthritis.

Amounts of HY-50 Vet to be administered and administration route:

  • Intravenous route: The recommended dose of HY-50 is 51 mg hyaluronate sodium (contents of one syringe) once a week for three consecutive weeks.

  • Intra-articular route: The recommended dose of HY-50 is 51 mg hyaluronate sodium (contents of one syringe) in small or medium sized joints (i.e. carpus, fetlock) by intra-articular injection. More than one joint may be treated at the same time. Treatment may be repeated after one or more weeks if necessary, but not to exceed four consecutive weekly injections in the same joint. HY-50 should be administered using strict aseptic technique. The site should be surgically prepared to ensure removal of all dirt, hair, topical medicaments, and soapy residues.

  • Intra-articular injections should not be made through skin that has been recently red or blistered or that has been scurfed by the use of counterirritants. After introducing the needle into the joint, excess synovial uid should be allowed to drain, or should be removed when possible, prior to attaching the syringe and injecting HY-50. Discard any unused portion of a syringe. A sterile dressing and clean bandage should be applied after injection, as appropriate for the particular joint treated. Hand walk for at least 2 days after treatment. Return to strenuous exercise will depend on the severity of each case and the regression of clinical signs.
72.20
Order within 13h 37m 38s (before 12AM)
And receive your order
on Monday 21 October
AIR FREIGHT

Customers who buy this product, usually buy: